BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25306899)

  • 1. Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias.
    Tursky ML; Beck D; Thoms JA; Huang Y; Kumari A; Unnikrishnan A; Knezevic K; Evans K; Richards LA; Lee E; Morris J; Goldberg L; Izraeli S; Wong JW; Olivier J; Lock RB; MacKenzie KL; Pimanda JE
    Leukemia; 2015 Apr; 29(4):819-27. PubMed ID: 25306899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
    Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
    Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
    Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
    Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
    Martens JH; Mandoli A; Simmer F; Wierenga BJ; Saeed S; Singh AA; Altucci L; Vellenga E; Stunnenberg HG
    Blood; 2012 Nov; 120(19):4038-48. PubMed ID: 22983443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.
    Huang Y; Thoms JA; Tursky ML; Knezevic K; Beck D; Chandrakanthan V; Suryani S; Olivier J; Boulton A; Glaros EN; Thomas SR; Lock RB; MacKenzie KL; Bushweller JH; Wong JW; Pimanda JE
    Leukemia; 2016 Jul; 30(7):1552-61. PubMed ID: 27055868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
    Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
    PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
    Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
    Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
    Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
    Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
    Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
    Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to
    Porter SN; Cluster AS; Yang W; Busken KA; Patel RM; Ryoo J; Magee JA
    Elife; 2016 Nov; 5():. PubMed ID: 27879203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
    Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
    Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13.
    Imren S; Heuser M; Gasparetto M; Beer PA; Norddahl GL; Xiang P; Chen L; Berg T; Rhyasen GW; Rosten P; Park G; Moon Y; Weng AP; Eaves CJ; Humphries RK
    Blood; 2014 Dec; 124(24):3608-12. PubMed ID: 25339361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
    Fatrai S; Schepers H; Tadema H; Vellenga E; Daenen SM; Schuringa JJ
    Exp Hematol; 2008 Oct; 36(10):1254-65. PubMed ID: 18640764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of MN1 sequences necessary for myeloid transformation.
    Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
    PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
    Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
    Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
    Thanasopoulou A; Tzankov A; Schwaller J
    Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.